Losartan reverses fibrotic changes in cortical renal tissue induced by ischemia or ischemia-reperfusion without changes in renal function

Molecular and Cellular Biochemistry

Volumn 260, Issue 1, 2004, Pages 161-170

  Barrilli, Andrés ^a   Molinas, Sara ^a   Petrini, Guillermo ^a   Menacho, Mauricio ^a   Elías, María Mónica ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

Acute renal failure; Fibronectin; Ischemia; Ischemia reperfusion; Losartan; Metalloproteases

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CALCIUM; FIBRONECTIN; LOSARTAN; MATRIX METALLOPROTEINASE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; KIDNEY CORTEX; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE HOMOGENATE; WESTERN BLOTTING;

ANIMALS; BLOOD UREA NITROGEN; FIBRONECTINS; FIBROSIS; GLOMERULAR FILTRATION RATE; ISCHEMIA; KIDNEY CORTEX; KIDNEY FUNCTION TESTS; KIDNEY TUBULES, PROXIMAL; LOSARTAN; MALE; MATRIX METALLOPROTEINASES; POTASSIUM; RATS; RATS, WISTAR; REPERFUSION INJURY; SODIUM; WATER;

EID: 4344583568     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000026068.38301.cf     Document Type: Article

References (57)

1. Toback FG: Regeneration after acute tubular necrosis. Kidney Int 41: 226-246, 1992
2. Venkathalam MA, Bernard DB, Donohoe J, Levinsky NG: Ischemic damage and repair in the rat proximal tubule. Differences among S1, S2 and S3 segments. Kidney Int 14: 31-49, 1978
3. Okada H, Strutz F, Danoff TM, Neilson EG: Possible pathogenesis of renal fibrosis. Kidney Int 49: S37-S38, 1996
4. Terzi F, Burtin M, Friedlander G: Early molecular mechanisms in the progression of renal failure: Role of growth factors and protooncogenes. Kidney Int 53: S68-S73, 1998
5. Safirstein R. Gene expression in nephrotoxic and ischemic acute renal failure. J Am Soc Nephrol 4: 1387-1395, 1994
6. Klahr S, Schreiner G, Ichikawa J: The progression of renal disease. New Engl J Med 318: 1657-1666, 1988
7. Kuncio GS, Nelson EG, Haverty T: Mechanisms of tubulointerstitial fibrosis. Kidney Int 39: 550-556, 1991
8. Ignoz RA, Massagne J: Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261: 4337-4345, 1986
9. Ong ACM, Fine HG: Loss of glomerular function and tubulointerstitial fibrosis: Cause and effect. Kidney Int 39: 401-420, 1991
10. Eddy AA, Giachelli CM: Renal expression of genes that promote interstitial inflamation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47: 1546-1557, 1995
11. Wolf G, Neilson EG: Molecular Mechanims of tubulointerstitial hyperthrophy and hyperplasia. Kidney Int 39: 401-420, 1991
12. Jones C, Buch S, Post M, Mc Culloch H, Hin E, Eddy AE: Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. Kidney Int 40: 1020-1031, 1991
13. Basile PD, Martin DR, Hammerman MR. Extracellular matrix-related genes in kidney after ischemic injury: Potential role for TGF-β in repair. Am J Physiol 275: F894-F903, 1998
14. Zuk A, Bonventre JV, Brown D, Matlin KS: Polarity, integrin, and extracellular matrix dynamics in the postischemic rat kidney. Am J Physiol 275: C711-C731, 1998
15. Viedt C, Bürger A, Hänsch GM: Fibronectin synthesis in tubular epithelial cells: Up-regulation of the EDA splice variant by transforming growth factor β. Kidney Int 48: 1810-1817, 1995
16. Burton CJ, Combe C, Walls J, Harris KPG: Fibronectin production by human tubular cells: The effect of apical protein. Kidney Int 50: 760-767, 1996
17. Morrisey K, Steadman R, Williams JD, Phillips AO: Renal proximal tubular cell fibronectin accumulation in response to glucose is polyol pathway dependent. Kidney Int 55: 160-167, 1999
18. Bürger A., Wagner Ch, Viedt C, Reis B, Hug F, Hänsch GM: Fibronectin synthesis by human tubular ephitelial cells in culture: Effects of PDGF and TGF-β on synthesis and splicing. Kidney Int: 54: 407-415, 1998
19. Petrini G, Ochoa EJ, Serra E, Torres AM, Elías MM: Fibronectin expression in proximal tubules from ischemic rat kidneys without reperfusion. Moll Cell Biochem 241: 21-27, 2002
20. Yoo KH, Thornhill BA, Chevalier RL: Angiotensin stimulates TGF-β and clusterin in the hydronephrotic neonatal rat kidney. Am J Physiol 278: R640-R645, 2000
21. Campistol JM, Iñigo P, Jimenez W, Lario S, Clesca PH, Oppenheimer F, Rivera F: Losartan decreases plasma levels of TGF-β1 in transplant patients with cronic allograft nephropathy. Kidney Int 56: 714-719, 1999
22. Kontogiannis J., Burns KD: Role of AT1 angiotensin II receptors in renal ischemic injury. Am J Physiol 274: F79-F90, 1998
23. Nakamura T, Takahashi T, Fukui M, Ebihara I, Osada S, Tomino Y, Koide H: Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats. J Am Soc Nephrol 5: 1492-1497
24. Reinhardt D, Sigusch HH, Hensse J, Tyagi SC, Korfer R, Figulla HR: Cardiac remodelling in end stage heart failure: upregulation of matrix matalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP. Heart 88: 525-530, 2002
25. Peters H, Border WA, Noble NA: Targeting TGF-beta overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade. Kidney Int 54: 1570-1580, 1998
26. Khalil A, Tullus K, Bakhiet M, Burman LG, Jaremko G, Brauner A: Angiotensin II type 1 receptor antagonist (losartan) down-regulates transforming growth factor-β in experimental acute pyelonephritis. J Urol 164: 186-191, 2000
27. +-ATPase activity, abundance and distribution after in vivo renal ischemia without reperfusion in rats. Nephron 89: 82-89, 2001
28. Vinay P, Gougoux A, Lemieux G: Isolation of a pure suspension of rat proximal tubules. Am J Physiol 241: F403-F411, 1981
29. Brunette MG, Chan M, Lebrun M: Phosphatase activity along the nephron of mice with hypophosphatemic vitamin-D-resistant rickets. Kidney Int 20: 181-188, 1981
30. 2+ indication with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985
31. Proksch JW, Traylor LA, Mayeux PR: Effects of lipid A on calcium homeostasis in renal proximal tubules. J Pharmacol Exp Ther 276: 555-560, 1996
32. Sedmak JJ, Grossberg SE: A rapid, sensitive and versatile assay for protein using Coomassie Brilliant Blue G-250. Anal Biochem 79: 544-552, 1971
33. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970
34. Towbin H, Staehelim T, Gordon J: Electroforetic transfer of protein from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4353, 1979
35. Kretzler M, Fan G, Rose D, Arend LJ, Brigg JP, Holzman LB: Novel mouse embryonic renal marker gene products differentially expressed during kidney development. Am J Physiol 271: 770-777, 1996
36. Schwarzbauer JE, Tamkun JW, Lenischka IR, Hynes RO: Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell 35: 421-431, 1983
37. Kleiner DE, Stetler-Stevenson WG.: Quantitative zimography: Detection of picogram quantities of gelatinases. Anal Biochem218: 325-329, 1994
38. Brady HR, Brenner BM, Lieberthal W: Acute renal failure. In: B.M. Brenner (ed). The Kidney, vol. 2. W.B. Saunders Company, Boston, Massachusetts, 1996, pp 1200-1252
39. Ward RV, Hembry RM, Reynols JJ, Murphy G: The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex: Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1. Biochem J 278: 179-187, 1991
40. Hanemaaijer R, Koolwijk P, Le Clercq L, De Vree WJ, Van Hinsbergh VW: Regulation of matrix metalloproteinase expression in human vein and microvascular endotelial cells: Effects of tumor necrosis factor β, interleukin 1 and phorbol ester. Biochem J 296: 803-809, 1993
41. Eberhardt W, Beeg T, Beck KF, Walpen S, Gauer S, Böhles H, Pfeilschifter J: Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells. Kidney Int 57: 59-69, 2000
42. +K)-ATPase activity, abundance and distribution after ischaemia-reperfusion in rats. Biochim Biophys Acta 62072: 1-10, 2001
43. Molitoris BA, Marrs J: The role of cell adhesion molecules in ischemic acute renal failure. Am J Med 106: 583-592, 1999
44. Fernandez Lama P, Andrews P, Turner R, Saggi S, Dimari J, Kwon T, Nielsen S, Safirstein R, Knepper M: Decreased abundance of collecting duct aquaporins in post ischemic renal failure in rats. J Am Soc Nephrol 10: 1658-1668, 1999
45. + transporters in kidneys of rats with ischemia-induced acute renal failure. Am J Physiol 278: F925-F939, 2000
46. Smoyer WE, Ransom R, Harris RC, Welsh MJ, Lutsch G, Benndorf R: Ischemic acute renal failure induces differential expression of small heat shock proteins. J Am Soc Nephrol 11: 211-221, 2000
47. Miyagima A, Chen J, Lawrence C, Ledbetter S, Soslow RA, Stern J, Jha S, Pigato J, Lemer ML, Poppas DP, Darracott Vaughan E, Felsen D: Antibody to transforming growth factor-β ameliorates tubular apoptosis in unilateral obstruction. Kidney Int 58: 2301-2313, 2000
48. Zuk A, Bonventre JV, Matlin KS: Expression of fibronectin splice variants in the postischemic rat kidney. Am J Physiol 280: F1037-F1053, 2001
49. Eddy AA: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7: 2495-2508, 1996
50. Lodisch H, Baltimore D, Berk A, Zipursky L, Matsudaira P, Darnell J: In: Molecular Cell Biology, 3rd edn, Chapter 16. ?Publisher, Town,? 1995, pp 669-738
51. Kazes I, Delarue F, Hagege J, Bouzhir-Sima L, Sraer JD, Nguyen G: Soluble latent membrane-type 1 matrix metalloprotease secreted by human mesangial cells is activated by urokinase. Kidney Int 54: 1976-1984, 1998
52. Martin J, Lovett D, Gemsa D, Sterzel R, Davies M: Enhancement of glomerular mesangial cell neutral proteinase secretion by macrophages: Role of interleukin 1. J Immumol 137: 525-529, 1986
53. Martin J, Knowlden J, Davies M, Willams JD: Identification and independent regulation of human mesangial cell metalloproteinases. Kidney Int 46: 877-885, 1994
54. Bafetti LM, Young TN, Itoh Y, Stak MS: Intact vitronectin induces matrix metalloproteinases-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells. J Biol Chem 273: 143-149, 1998
55. Martin J, Eynstone L, Davies M, Stead R: Induction of metalloproteinases by glomerular mesangial cells stimulated by proteins of the extracellular matrix. J Am Soc Nephrol 12: 88-96, 2001
56. Brenner BM, Zagrobelny JA: Clinical renoprotection trials involving angiotensinII-receptor antagonists and angiotensin-converting-enzyme inhibitors. Kidney Int 63(suppl 83): S77-S85, 2003
57. Satoh M, Kashihara N, Yamasaki Y, Maruyama K, Okamoto K, Maeshima, Y, Sugiyama H, Sugaya T, Murakami K, Makino H: Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 12: 317-325, 2001